Navigation Links
Inhibitex Prices $47 Million Public Offering
Date:4/7/2011

ctusrequest@list.db.com.  Electronic copies of the prospectus supplement and accompanying prospectus will also be available on the website of the SEC at http://www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy shares of common stock of Inhibitex, Inc., nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About InhibitexInhibitex, Inc. is a clinical stage biopharmaceutical company focused on developing products to prevent and treat serious infectious diseases.  The Company's pipeline includes FV-100, which is in Phase 2 clinical development for the treatment of shingles, and INX-189, a nucleotide polymerase inhibitor in Phase 1 clinical development for the treatment of chronic hepatitis C infections.  The Company also has additional HCV nucleotide polymerase inhibitors in preclinical development and has licensed the use of its proprietary MSCRAMM® protein platform to Pfizer for the development of staphylococcal vaccines.  For additional information about the Company, please visit www.inhibitex.com.

Inhibitex® and MSCRAMM® are registered trademarks of Inhibitex, Inc.

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements are often, but are not always, made through the use of words or phrases such as "anticipates," "intends," "estimate," "plans," "expects," "we believe," "we intend," and similar words or phrases, or future or conditional verbs such as "will," "would," "should," "potential," "could," "may," or similar expressions.  These statements  invo
'/>"/>

SOURCE Inhibitex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
2. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
3. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
5. Warner Chilcott Prices Secondary Equity Offering
6. Neurocrine Biosciences, Inc. Prices Common Stock Offering
7. NCPA: AARP Report Finds Brand Name Drug Prices Soar as Large Pharmacy Benefit Managers Reap Windfall Profits
8. Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015
9. Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market
10. As Drug Prices Rise, Seniors are Advised to Review Their Medicare Prescription Coverage
11. Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 The Physician-Patient Alliance for ... July 28, 2015, "Surviving Your Hospital Stay: Physician-Patient ... Patient Safety." A sentence was omitted ... "PPAHS is a member of the National ... more information on the National Coalition to Promote ...
(Date:7/31/2015)... LONDON , July 31, 2015 ... to decades of experience, the domestic pharmaceutical industry is ... today manufacture products to high international standards. ... well known is in sub-Saharan Africa: Morocco has quietly ... after South Africa . Indeed, Moroccan ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... 16 Berlin Heart Inc. today announced,its EXCOR(R) Pediatric ... ongoing IDE clinical trial in the United,States of America. ... the Investigational Plan for the IDE study of the ... approval for the prospective,IDE study to begin initially at ...
... Australia, Oct. 16 Cytopia Limited (ASX:,CYT) will ... two important,scientific meetings this month., Dr Emmanuelle ... a,lecture entitled Targeted JAK2 Inhibitors for Myeloproliferative Disorders,at ... Australia and New,Zealand, in Perth, Australia, on 21 ...
Cached Medicine Technology:Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 2Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 3Cytopia Scientific Presentations on JAK2 Inhibitor Program 2
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of ... Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto ... in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, ...
(Date:7/31/2015)... ... ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and black ... Exilis non-surgical fat reduction in New York. Due to its unparalleled level of ... Many patients travel to New York to get their non-surgical skin tightening and ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... , ... July 31, 2015 , ... M3 USA MDLinx.com, ... to launch three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology ... Exam Prep from MDLinx makes preparing for the exam easy and painless. MDLinx ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... cholesterol lowering drugs known as statins may help prevent future ... The study is published in the August 2, 2011, print ... American Academy of Neurology. "Because the cause of ... drugs are often not used to prevent further strokes or ...
... , MONDAY, Aug. 1 (HealthDay News) -- Teens are ... in or go to school in neighborhoods with many fast ... study finds. Researchers compared 2007 data on junk food ... of junk food outlets, such as fast food restaurants, convenience ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Aug. ... who have been prescribed a controlled medication such as Oxycontin ... are misusing the drugs, a new study has found. ... abuse other substances and to start giving or selling drugs ...
... , Prostate cancer is the number two killer of American men, ... affects more than 2 million American men, and in 2010 there ... kills, but even for those who survive it, the world is ... and depression are common after-effects of prostate cancer, and until now ...
... By Serena Gordon HealthDay Reporter , MONDAY, Aug. ... of the omega 3 fatty acid DHA during pregnancy, their ... indicates. At 1 month and 3 months of age, ... in the womb experienced cold symptoms, compared to about 45 ...
... of Technology (MIT) have developed a new imaging system ... changes in the esophagus or colon. The new system, ... Biomedical Optics Express , is based on an ... a way to see below the surface with 3-D, ...
Cached Medicine News:Health News:Cholesterol-lowering drugs may help prevent recurrent strokes in younger people 2Health News:With Junk Food Stores Nearby, Teens May Eat More of It 2Health News:When Teens Abuse Prescriptions, Addiction Often Follows 2Health News:When Teens Abuse Prescriptions, Addiction Often Follows 3Health News:Prenatal Omega-3 Fatty Acid Supplements May Cut Babies' Colds 2Health News:Prenatal Omega-3 Fatty Acid Supplements May Cut Babies' Colds 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 4
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps straight ends size 3.5"....
Removal Forceps, very fine pointed tips, with textured jaws, ideal for grasping wet sutures....
Forceps, extra delicate, straight....
Medicine Products: